HIV and HCV co-infection: Situation at six French University Hospitals in the year 2000

Journal of Medical Virology

Volumn 69, Issue 1, 2003, Pages 7-17

  Buffet Janvresse, Claudine ^a   Peigue Lafeuille, Hélène ^b   Benichou, Jacques ^a   Vabret, Astrid ^d   Branger, Michel ^c   Trimoulet, Pascale ^e   Goria, Odile ^a   Laurichesse, Henri ^b   Abbed, Abdelaziz ^f   Verdon, Renaud ^d   Bouvet, Elisabeth ^c   Lafon, Marie Edith ^e   Dussaix, Elisabeth ^f   Cormerais, Louis ^b   Dupon, Michel ^g   Henquell, Cécile ^b   Josse, Annie ^h   Lagoutte, Philippe ^a   Lariven, Sylvie ^c   LeGac, Sylvie ^c   Neau, Didier ^g   Riachi, Ghassan ^a   Vittecoq, Didier ^f   more..

^a UNIVERSITÉ DE ROUEN   (France)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

^c BICHAT HOSPITAL   (France)

^d UNIVERSITÉ DE CAEN   (France)

^e UNIVERSITÉ DE BORDEAUX   (France)

^f HÔPITAL PAUL BROUSSE   (France)

^g Service des Maladies Infectieuses   (France)

^h CISIH   (France)

Author keywords

HAART; HCV; HIV; Interferon; Liver biopsy; Ribavirin; Sociodemographic characteristics

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; CD4 ANTIGEN; INTERFERON; RIBAVIRIN; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ARTICLE; COMORBIDITY; DISEASE TRANSMISSION; FEMALE; FRANCE; HEPATITIS C; HEPATITIS C VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; LEUKOCYTE COUNT; LIVER BIOPSY; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; UNIVERSITY HOSPITAL; VIRUS INFECTION; VIRUS TRANSMISSION;

ADULT; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; FEMALE; FRANCE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HIV INFECTIONS; HOSPITALS, UNIVERSITY; HUMANS; INTERFERONS; LIVER; MALE; QUESTIONNAIRES; RISK FACTORS; RNA, VIRAL; SUBSTANCE ABUSE, INTRAVENOUS;

HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; MARTES PENNANTI;

EID: 0037211571     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.10268     Document Type: Article

References (77)

1. Barbaro G, Di Lorenzo G, Soldini M, Parrotto S, Bellomo G, Belloni G, Grisorio B, Barbarini G. 1996. Hepatic glutathione deficiency in chronic hepatitis C: Quantitative evaluation in patients who are HIV positive and HIV negative and correlations with plasmatic and lymphocytic concentrations and with the activity of the liver disease. Am J Gastroenterol 91:2569-2573.
2. Bedossa P, Poynard T. 1996. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 24:289-293.
3. Beld M, Penning M, Lukashov V, McMorrow M, Roos M, Pakker N, van den Hoek A, Goudsmit J. 1998. Evidence that both HIV and HIV-induced immunodeficiency enhance HCV replication among HCV seroconverters. Virology 244:504-512.
4. Benhamou Y, Bochet M, Di Martino V, Charlotte F, Azria F, Coutellier A, Vidaud M, Bricaire F, Opolon P, Katlama C, Poynard T. 1999. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. Hepatology 30:1054-1058.
5. Benhamou Y, Di Martino V, Bochet M, Colombet G, Thibault V, Liou A, Katlama C, Poynard T. 2001. Factors affecting liver fibrosis in human immunodeficiency virus-and hepatitis C virus-coinfected patients: Impact of protease inhibitor therapy. Hepatology 34:283-287.
6. Bierhoff E, Fischer HP, Willsch E, Rockstroh J, Spengler U, Brackmann HH, Oldenburg J. 1997. Liver histopathology in patients with concurrent chronic hepatitis C and HIV infection. Virchows Arch 430:271-277.
7. Bochet M, De Torres M, Valantin MA, Thibault V, Poynard T, Katlama C, Benhamou Y. 2001. Efficacy and tolerance of IFN α; plus Ribavirin for chronic hepatitis C in HIV-infected patients. 8th Conference on Retroviruses and Opportunistic Infection. Chicago. Abstract 574.
8. Bonacini M. 1999. Retrospective analysis of the impact of HIV infection and alcohol use on chronic hepatitis C in a large cohort of drug users. J Hepatol 30:347-348.
9. Bonacini M, Puoti M. 2000. Hepatitis C in patients with human immunodeficiency virus infection: Diagnosis, natural history, metaanalysis of sexual and vertical transmission, and therapeutic issues. Arch Intern Med 160:3365-3373.
10. Bonacini M, Govindarajan S, Blatt LM, Schmid P, Conrad A, Lindsay KL. 1999. Patients co-infected with human immunodeficiency virus and hepatitis C virus demonstrate higher levels of hepatic HCV RNA. J Viral Hepatol 6:203-208.
11. Cacoub P, Geffray L, Rosenthal E, Personne C, Veyssier P, Raguin G. 2001. Mortality among human immunodeficiency virus-infected patients with cirrhosis or hepatocellular carcinoma due to hepatitis C virus in French Departments of internal medicine/infectious diseases, in 1995 and 1997. Clin Infect Dis 32:1207-1214.
12. Chamot E, Hirschel B, Wintsch J, Robert CF, Gabriel V, Deglon JJ, Yerly S, Perrin X. 1990. Loss of antibodies against hepatitis C virus in HIV-seropositive intravenous drug users. AIDS 4:1275-1277.
13. Cribier B, Rey D, Schmitt C, Lang JM, Kirn A, Stoll-Keller F. 1995. High hepatitis C viraemia and impaired antibody response in patients coinfected with HIV. AIDS 9:1131-1136.
14. Daar ES, Lynn H, Donfield S. 2000. The relationship between hepatitis C virus and HIV infection in hemophiliacs [abstract 280]. In: Program and Abstracts of the Seventh Conference on Retroviruses and Opportunistic Infections, San Francisco, CA.
15. Daar ES, Lynn H, Donfield S, Gomperts E, Hilgartner NW, Hoots WK, Chernoff D, Arkin S, Wong WY, Winkler CA. 2001a. Relation between HIV-1 and hepatitis C viral load in patients with hemophilia. J Acquir Immune Defic Syndr 26:466-472.
16. Daar ES, Lynn H, Donfield S, Gomperts E, O'Brien SJ, Hilgartner MW, Hoots WK, Chernoff D, Arkin S, Wong WY, Winkler CA. 2001b. Hepatitis C virus load is associated with human immunodeficiency virus type 1 disease progression in hemophiliacs. J Infect Dis 183:589-595.
17. Darby SC, Ewart DW, Giangrande PL, Spooner RJ, Rizza CR, Dusheiko GM, Lee CA, Ludlam CA, Preston FE. 1997. Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. Lancet 350:1425-1431.
18. Devereux H, Telfer P, Dusheiko G, Lee C. 1995. Hepatitis C genotypes in haemophilic patients treated with alpha-interferon. J Med Virol 45:284-287.
19. Devereux H, Telfer P, Brown D, Morris A, Dusheiko G, Emery V, Lee C. 1996. Longitudinal genotype analysis and quantification of hepatitis C virus in haemophilic patients receiving interferon-alpha therapy. J Viral Hepatol 3:43-48.
20. Di Martino V, Rufat P, Boyer N, Renard P, Degos F, Martinot-Peignoux M, Matheron S, Le Moing V, Vachon F, Degott C, Valla D, Marcellin P. 2001. The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: A long-term retrospective cohort study. Hepatology 34:1193-1199.
21. Dieterich D, Jones-Mangialardi W, Thommes J. 1998. Elevated liver enzymes in patients on protease inhibitors with and without markers for hepatitis: Results from the CHORUS observational database [abstract H-115]. In: Thirty-Eighth ICAAC, San Diego, CA.
22. Dorrucci M, Pezzotti P, Phillips AN, Lepri AC, Rezza G. 1995. Coinfection of hepatitis C virus with human immunodeficiency virus and progression to AIDS. Italian Seroconversion Study. J Infect Dis 172:1503-1508.
23. Duong M, Petit JM, Piroth L, Grappin M, Buisson M, Chavanet P, Hillon P, Portier H. 2001. Association between insulin resistance and hepatitis C virus chronic infection in HIV-hepatitis C virusco-infected patients undergoing antiretroviral therapy. J Acquir Immune Defic Syndr 27:245-250.
24. Eyster ME, Diamondstone LS, Lien JM, Ehmann WC, Quan S, Goedert JJ. 1993. Natural history of hepatitis C virus infection in multitransfused hemophiliacs: Effect of coinfection with human immunodeficiency virus. J Acquir Immune Defic Syndr 6:602-610.
25. Eyster ME, Sherman KE, Goedert JJ, Katsoulidou A, Hatzakis A. 1999. Prevalence and changes in Hepatitis C virus genotypes among multitransfused persons with hemophilia. J Infect Dis 179:1062-1069.
26. Garcia-Samaniego J, Soriano V, Castilla J, Bravo R, Moreno A, Carbo J, Iniguez A, Gonzalez J, Munoz F. 1997. Influence of hepatitis C virus genotypes and HIV infection on histological severity of chronic hepatitis C. Am J Gastroenterol 92:1130-1134.
27. Garcia-Samaniego J, Bravo R, Gomez-Cano M, Soriano V. 1998. Lack of benefit of protease inhibitors on HCV viremia in HIV-infected patients. J Hepatol 28:526-527.
28. Gavazzi G, Bouchard O, Leclercq P, Morel-Baccard C, Bosseray A, Dutertre N, Micoud M, Morand P. 2000. Change in transaminases in HCV and HIV coinfected patients after HAART: Differences between complete and partial virologic responders? AIDS Res Hum Retroviruses 16:1021-1023.
29. Ghany MG, Leissenger C, Lagier R, Sanchez-Pescador R, Lok AS. 1996. Effect of human immunodeficiency virus infection on hepatitis C virus infection in hemophiliacs. Dig Dis Sci 41:1265-1272.
30. Greub G, Ledergerber B, Battegay M, Grob P, Perrin L, Furrer H, Burgisser P, Erb P, Boggian K, Piffaretti JC, Hirschel B, Janin P, Francioli P, Flepp M, Telenti A. 2000. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: The Swiss HIV cohort study. Lancet 356:1800-1805.
31. Guignon N. 2002. Le Recours Aux Soins Hospitaliers Pour Hépatite C Chronique. Résultat des Enquêtes 2000, 1999 et 1998. Ministère de l'Emploi et de la Solidarité. Document de travail DREES 31:01-20.
32. Gulick RM, Mellors JW, Havlir D, Eron JJ, Gonzalez C, McMahon D, Richman DD, Valentine FT, Jonas L, Meibohm A, Emini EA, Chodakewitz JA. 1997. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med 337:734-739.
33. Hammer SM, Squires KE, Hughes MD, Grimes JM, Demeter LM, Currier JS, Eron JJ Jr, Feinberg JE, Balfour HH Jr, Deyton LR, Chodakewitz JA, Fischl MA. 1997. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N Engl J Med 337:725-733.
34. Hayashi PH, Flynn N, McCurdy SA, Kuramoto IK, Holland PV, Zeldis JB. 1991. Prevalence of hepatitis C virus antibodies among patients infected with human immunodeficiency virus. J Med Virol 33:177-180.
35. Haydon GH, Flegg PJ, Blair CS, Brettle RP, Burns SM, Hayes PC. 1998. The impact of chronic hepatitis C virus infection on HIV disease and progression in intravenous drug users. Eur J Gastroenterol Hepatol 10:485-489.
36. Horvath J, Raffanti SP. 1994. Clinical aspects of the interactions between human immunodeficiency virus and the hepatotropic viruses. Clin Infect Dis 18:339-347.
37. Jarvis LM, Ludlam CA, Ellender JA, Nemes L, Field SP, Song E, Chuansumrit A, Preston FE, Simmonds P. 1996. Investigation of the relative infectivity and pathogenicity of different hepatitis C virus genotypes in hemophiliacs. Blood 87:3007-3011.
38. Kane A, Lloyd J, Zaffran M, Simonsen L, Kane M. 1999. Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: Model-based regional estimates. Bull WHO 77:801-807.
39. Kaplan AJ, Zone-Smith LK, Hannegan C, Norcross ED. 1992. The prevalence of hepatitis C in a regional level I trauma center population. J Trauma 33:126-128.
40. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J. 1981. Formulation and application of numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1:431-435.
41. Lesens O, Deschenes M, Steben M, Belanger G, Tsoukas CM. 1999. Hepatitis C virus is related to progressive liver disease in human immunodeficiency virus-positive hemophiliacs and should be treated as an opportunistic infection. J Infect Dis 179:1254-1258.
42. Marcellin P, Colin JF, Martinot-Peignoux M, Pham BN, Lefort V, Picault AB, Degott C, Erlinger S, Benhamou JP. 1993. Hepatitis C virus infection in anti-HIV positive and negative French homosexual men with chronic hepatitis: Comparison of second-and third-generation anti-HCV testing. Liver 13:319-322.
43. Martin P, Di Bisceglie AM, Kassianides C, Lisker-Melman M, Hoofnagle JH. 1989. Rapidly progressive non-A, non-B hepatitis in patients with HIV infection. Gastroenterology 97:1559-1561.
44. Mendel I, Clotteau L, Lambert S, Buffet-Janvresse C. 1995. Hepatitis C virus infection in an HIV-positive population in Normandy: Antibodies, HCV RNA and genotype prevalence. J Med Virol 47:231-236.
45. Michelet C, Chapplain JM, Petsaris O, Arvieux C, Ruffault A, Lotteau V, Andre P. 1999. Differential effect of ritonavir and indinavir on immune response to hepatitis C virus in HIV-1 infected patients. AIDS 13:1995-1996.
46. Nadal JM. 2000. Chiffres Clés Sida et Hépatite C. Ministère de l'Emploi et de la Solidarité. Médecine-Sciences Flammarion 10-60.
47. Neau D, Trimoulet P, Winnock M, Le Bail B, Schvoerer E, Legrand E, Ragnaud JM, Dupon M, Fleury H, Lafon ME. 2001. Impact of protease inhibitors on intrahepatic hepatitis C virus viral load. AIDS 7:1736-1738.
48. Newell A, Nelson M. 1998. Infectious hepatitis in HIV-seropositive patients. Int J STD AIDS 9:63-69.
49. Pawlotsky JM. 1997. Measuring hepatitis C viremia in clinical samples: Can we trust the assays? Hepatology 26:1-4.
50. Piroth L, Duong M, Quantin C, Abrahamowicz M, Michardiere R, Aho LS, Grappin M, Buisson M, Waldner A, Portier H, Chavanet P. 1998. Does hepatitis C virus co-infection accelerate clinical and immunological evolution of HIV-infected patients? AIDS 12:381-388.
51. Piroth L, Bourgeois C, Dantin S, Waldner A, Grappin M, Portier H, Chavanet P. 1999. Hepatitis C virus (HCV) genotype does not appear to be a significant prognostic factor in HIV-HCV-coinfected patients. AIDS 13:523-524.
52. Pol S, Fontaine H, Carnot F, Zylberberg H, Berthelot P, Brechot C, Nalpas B. 1998. Predictive factors for development of cirrhosis in parenterally acquired chronic hepatitis C: A comparison between immunocompetent and imunocompromised patients. J Hepatol 29:12-19.
53. Puoti M, Bonacini M, Spinetti A, Putzolu V, Govindarajan S, Zaltron S, Favret M, Gallea F, Gargiulo F, Donato F, Carosi G. 2001. Liver fibrosis progression is related to CD4 cell depletion in patients coinfected with hepatitis C virus and human immunodeficiency virus. J Infect Dis 183:134-137.
54. Quaranta J, Delaney S, Alleman S, Cassuto JP, Dellamonica P, Allain JP. 1994. Prevalence of antibody to hepatitis C virus in HIV-1 infected patients (Nice SEROCO cohort). J Med Virol 42:29-32.
55. Ragni MV, Belle SH. 2001. Impact of human immunodeficiency virus infection on progression to end-stage liver disease in individuals with hemophilia and hepatitis C virus infection. J Infect Dis 183:1112-1115.
56. Ragni MV, Ndimbie OK, Rice EO, Bontempo FA, Nedjar S. 1993. The presence of hepatitis C virus (HCV) antibody in human immunodeficiency virus-positive hemophilic men undergoing HCV "seroreversion." Blood 82:1010-1015.
57. Rodriguez-Rosado R, Garcia-Samaniego J, Soriano V. 1998. Hepatotoxicity after introduction of highly active antiretroviral therapy. AIDS 12:1256.
58. Rutschmann OT, Negro F, Hirschel A, Hadengue A, Anwar D, Perrin LH. 1998. Impact of treatment with human immunodeficiency virus (HIV) protease inhibitors on hepatitis C viremia in patients coinfected with HIV. J Infect Dis 177:783-785.
59. Saadeh S, Cammell G, Carey WD, Younossi Z, Barnes D, Easley K. 2001. The role of liver biopsy in chronic hepatitis C. Hepatology 33:196-200.
60. Sabin G, Telfer P, Phillips A, Bhagani S, Lee C. 1997. The association between hepatitis C virus genotype and HIV disease progression in a cohort of hemophilic men. J Infect Dis 175:164-168.
61. Sanchez-Quijano A, Andreu J, Gavilan F, Luque F, Abad MA, Soto B, Munoz J, Aznar JM, Leal M, Lissen E. 1995. Influence of HIV-1 on the natural course of chronic parenterally acquired hepatitis C. Eur J Clin Microbiol Infect Dis 14:949-953.
62. Shi Z, Wakil AE, Rockey DC, 1997. Strain-specific differences in mouse hepatic wound healing are mediated by divergent T helper cytokine responses. Proc Natl Acad Sci USA 94:10663-10668,
63. Soriano V, Garcia-Samaniego J, Rodriguez-Rosado R, Gonzalez J, Pedreira J. 1999a. Hepatitis C and HIV infection: Biological, clinical and therapeutic implications. J Hepatol 31 (suppl 1):119-123.
64. Soriano V, Rodriguez-Rosado R, Garcia-Samaniego J. 1999b. Management of chronic hepatitis C in HIV-infected patients. AIDS 13:539-546.
65. Soriano V, Kirk O, Antunes F. 2000. The influence of hepatitis C on the prognosis of HIV: The EuroSIDA Study [abstract ThOB655]. In: Thirteenth International AIDS Conference, Durban.
66. Soto B, Sanchez-Quijano A, Rodrigo L, Del Olmo JA, Garcia-Bengoechea M, Hernandez-Quero J, Rey C, Abad MA, Rodriguez M, Sales Gilabert M, Gonzalez F, Miron P, Caruz A, Relimpio F, Torronteras R, Leal M, Lissen E. 1997. Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. J Hepatol 26:1-5.
67. Stubbe L, Soriano V, Antunes F. 1998. Hepatitis C in the EuroSIDA Cohort of European HIV-infected patients: Prevalence and prognostic value [abstract 22261]. In: Twelfth World AIDS Conference, Geneva.
68. Sulkowski MS, Thomas DL, Chaisson RE, Moore RD. 2000. Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection. JAMA 283:74-80.
69. Thelot B, Pialoux G, Delhommeau A, Piroth L, Salmon-Céron D. 2000. Epidémiologie Hospitalière des Patients Coinfectés par le VIH et le VHC. Ministère de l'Emploi et de la Solidarité BEH 39:171-173.
70. Thomas DL, Astemborski J, Vlahov D, Strathdee SA, Ray SC, Nelson KE, Galai N, Nolt KR, Laeyendecker O, Todd JA. 2000. Determinants of the quantity of hepatitis C virus RNA. J Infect Dis 181:844-851.
71. Torriani FJ, Soriano V. 2000. Chronic hepatitis C in HIV-infected individuals. AIDS 2:168-177.
72. Toyoda H, Fukuda Y, Koyama Y, Takamatsu J, Saito H, Hayakawa T. 1997. Effect of immunosuppression on composition of quasispecies population of hepatitis C virus in patients with chronic hepatitis C coinfected with human immunodeficiency virus. J Hepatol 26:975-982.
73. Wejstal R. 1999. Sexual transmission of hepatitis C virus. J Hepatol 31 (suppl 1):92-95.
74. Woitas RP, Rockstroh JK, Beier I, Jung G, Kochan B, Matz B, Brackmann HH, Sauerbruch T, Spengler U. 1999. Antigen-specific cytokine response to hepatitis C virus core epitopes in HIV/hepatitis C virus-coinfected patients. AIDS 13:1313-1322.
75. Wright TL, Hollander H, Pu X, Held MJ, Lipson P, Quan S, Polito A, Thaler MM, Bacchetti P, Scharschmidt BF. 1994. Hepatitis C in HIV-infected patients with and without AIDS: Prevalence and relationship to patient survival. Hepatology 20:1152-1155.
76. Zylberberg H, Pialoux G, Carnot F, Landau A, Brechot C, Pol S. 1998. Rapidly evolving hepatitis C virus-related cirrhosis in a HIV-infected patient receiving triple antiretroviral therapy. Clin Infect Dis 27:1255-1258.
77. Zylberberg H, Nalpas B, Pol S, Brechot C, Viard JP. 2000. Is there a relationship between hepatitis C virus infection and antiretroviral-associated lipoatrophy. AIDS 14:2055.